卡铂和脂质体阿霉素用于治疗卵巢癌。
Carboplatin and Liposomal Doxorubicin for Ovarian Cancer.
作者信息
Nguyen Jamie, Solimando Dominic A, Waddell J Aubrey
出版信息
Hosp Pharm. 2016 Jun;51(6):442-9. doi: 10.1310/hpj5106-442.
Abstract
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: OncRxSvc@comcast.net; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: waddfour@charter.net.
摘要
癌症化疗的复杂性要求药剂师熟悉所使用的复杂治疗方案和高毒性药物。本专栏回顾了与抗肿瘤治疗的制备、调配和给药相关的各种问题，以及用于治疗恶性疾病的已上市和正在研究的药物。有关主题的问题或建议，请联系小多米尼克·A·索利曼多，肿瘤药学服务公司总裁，弗吉尼亚州阿灵顿市威尔逊大道4201号#110 - 545，邮编22203，电子邮件：OncRxSvc@comcast.net；或J·奥布里·沃德尔，田纳西大学药学院教授；布朗特纪念医院药学部肿瘤药剂师，田纳西州玛丽维尔市东拉马尔·亚历山大大道907号，邮编37804，电子邮件：waddfour@charter.net。
相似文献
1
Carboplatin and Liposomal Doxorubicin for Ovarian Cancer.卡铂和脂质体阿霉素用于治疗卵巢癌。
Hosp Pharm. 2016 Jun;51(6):442-9. doi: 10.1310/hpj5106-442.
2
Paclitaxel, Carboplatin, and trastuzumab.紫杉醇、卡铂和曲妥珠单抗。
Hosp Pharm. 2014 Nov;49(10):913-9. doi: 10.1310/hpj4910-913.
3
Blinatumomab and Pembrolizumab.博纳吐单抗和帕博利珠单抗。
Hosp Pharm. 2015 Apr;50(4):269-73. doi: 10.1310/hpj5004-269. Epub 2015 Apr 8.
4
Dinutuximab and Panobinostat.地努图希单抗和帕比司他。
Hosp Pharm. 2015 Oct;50(9):767-72. doi: 10.1310/hpj5009-767. Epub 2015 Oct 14.
5
Doxorubicin and Dacarbazine (AD) Regimen for Soft Tissue Sarcomas.多柔比星与达卡巴嗪（AD）联合方案治疗软组织肉瘤
Hosp Pharm. 2015 Mar;50(3):194-8. doi: 10.1310/hpj5003-194.
6
Drug Monographs: Ixazomib and Necitumumab.药品专论：伊沙佐米和奈昔妥珠单抗。
Hosp Pharm. 2016 May;51(5):362-6. doi: 10.1310/hpj5105-362.
7
Alectinib, Ceritinib, Elotuzumab, and Venetoclax.阿来替尼、色瑞替尼、埃罗妥珠单抗和维奈托克。
Hosp Pharm. 2016 Jul;51(7):524-34. doi: 10.1310/hpj5107-524.
8
Gefitinib and Sonidegib.吉非替尼和索尼德吉。
Hosp Pharm. 2015 Nov;50(10):868-872. doi: 10.1310/hpj5010-868. Epub 2015 Nov 19.
9
Nab-Paclitaxel and Carboplatin (Nab-PC) Regimen for Advanced Non-Small-Cell Lung Cancer.纳武单抗联合卡铂（Nab-PC）方案用于晚期非小细胞肺癌
Hosp Pharm. 2014 Oct;49(9):804-8. doi: 10.1310/hpj4909-804.
10
Drug Monographs: Avelumab and Ribociclib.药品说明书：阿维鲁单抗和瑞博西尼
Hosp Pharm. 2017 Jul;52(7):459-463. doi: 10.1177/0018578717719183. Epub 2017 Jul 17.
引用本文的文献
1
Cost effectiveness of bevacizumab plus carboplatin paclitaxel versus carboplatin paclitaxel as front line for advanced ovarian cancer in Thailand.在泰国，贝伐单抗联合卡铂和紫杉醇与卡铂和紫杉醇作为晚期卵巢癌一线治疗方案的成本效益比较
Sci Rep. 2025 Mar 22;15(1):9949. doi: 10.1038/s41598-025-94455-7.
2
Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics-A Review.抗氧化剂补充治疗铂类化疗药物引起的神经毒性：综述。
Int J Mol Sci. 2020 Oct 20;21(20):7753. doi: 10.3390/ijms21207753.
3
Frontline Management of Epithelial Ovarian Cancer-Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge Research.上皮性卵巢癌的一线管理——将临床专业知识与社区实践协作及前沿研究相结合
J Clin Med. 2020 Sep 1;9(9):2830. doi: 10.3390/jcm9092830.
4
Controlled Drug Release and Cytotoxicity Studies of Beta-Lapachone and Doxorubicin Loaded into Cyclodextrins Attached to a Polyethyleneimine Matrix.β-拉帕醌和阿霉素载入环糊精并连接到聚乙烯亚胺基质中的控释和细胞毒性研究。
Int J Mol Sci. 2020 Aug 14;21(16):5832. doi: 10.3390/ijms21165832.
本文引用的文献
1
A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer.聚乙二醇化脂质体阿霉素与卡铂用于铂敏感复发性卵巢癌、输卵管癌或原发性腹膜癌日本患者的II期临床试验。
Jpn J Clin Oncol. 2015 May;45(5):422-6. doi: 10.1093/jjco/hyv016. Epub 2015 Feb 10.
2
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇在非常铂类敏感卵巢癌患者中的比较：来自 CALYPSO Ⅲ期试验亚组分析的结果。
Eur J Cancer. 2015 Feb;51(3):352-8. doi: 10.1016/j.ejca.2014.11.017. Epub 2014 Dec 17.
3
Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.卡铂输注溶液在聚氯乙烯袋中0.9%氯化钠溶液中的稳定性研究。
J Oncol Pharm Pract. 2016 Feb;22(1):31-6. doi: 10.1177/1078155214546016. Epub 2014 Aug 12.
4
Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.采用 CKD-EPI 和 Cockcroft-Gault 公式并结合不同体重描述符计算低血清肌酐浓度肺癌患者的卡铂剂量。
Lung Cancer. 2013 Jan;79(1):54-8. doi: 10.1016/j.lungcan.2012.10.009. Epub 2012 Nov 4.
5
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.GCIG CALYPSO 试验中多柔比星脂质体与卡铂联合紫杉醇与卡铂治疗铂敏感卵巢癌患者的最终总生存结果。
Br J Cancer. 2012 Aug 7;107(4):588-91. doi: 10.1038/bjc.2012.307. Epub 2012 Jul 26.
6
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇在部分铂敏感卵巢癌患者中的比较：来自 CALYPSO Ⅲ期试验亚组分析的结果。
Ann Oncol. 2012 May;23(5):1185-1189. doi: 10.1093/annonc/mdr441. Epub 2011 Oct 5.
7
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.卡铂联合紫杉醇与卡铂联合聚乙二醇脂质体多柔比星作为卵巢癌一线治疗的比较：MITO-2 随机 III 期试验。
J Clin Oncol. 2011 Sep 20;29(27):3628-35. doi: 10.1200/JCO.2010.33.8566. Epub 2011 Aug 15.
8
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.老年卵巢癌患者：卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇治疗晚期复发：妇科癌症国际组织（GCIG）CALYPSO 子研究。
Ann Oncol. 2011 Nov;22(11):2417-2423. doi: 10.1093/annonc/mdr001. Epub 2011 Mar 14.
9
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.聚乙二醇脂质体阿霉素和卡铂与紫杉醇和卡铂治疗铂敏感复发性晚期卵巢癌患者的比较。
J Clin Oncol. 2010 Jul 10;28(20):3323-9. doi: 10.1200/JCO.2009.25.7519. Epub 2010 May 24.
10
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.卡铂联合聚乙二醇脂质体阿霉素与卡铂联合紫杉醇治疗铂敏感卵巢癌患者的随机 II 期研究：希腊肿瘤协作组研究。
BMC Med. 2010 Jan 7;8:3. doi: 10.1186/1741-7015-8-3.
Zotero 插件